WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 1-December 2016 (data as of 18-November-2016)
Next overall update June 2017
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 46'3601 Infant (under 12 months) mortality rate: 02
GDP / capita (US$): 40'6011 Child (under 5 years) mortality rate: 02

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 5'503  5'480  5'453  5'425  5'396  5'176  4'987  4'779 
Births 59  58  58  58  59  57  64  65 
Surviving infants 58  58  58  58  58  57  63  64 
Pop. less than 5 years 304  305  306  306  304  294  311  320 
Pop. less than 15 years 899  894  891  888  887  940  963  971 
Female 15-49 years 1'155  1'160  1'163  1'166  1'168  1'218  1'258  1'219 

Number of reported cases

(Click for retrospective incidence data for Finland)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  27  2'147 
Mumps
ChartChart
 
Pertussis
ChartChart
  165  192  555  707  187 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Finland)
Vaccine year result method % card seen                                                
BCG          99  91 
DTP1         
DTP3          97  98  99  99  99  90 
DTP4         
IPV1         
HepB_BD         
HepB3         
Hib3          97  98  99  99 
JapEnc         
MCV1          95  97  97  97  96  97 
MCV2         
PCV1         
PCV3          92 
Pol3          97  98  99  99  95  90 
Rota1          94 
RotaC          91  93 
RCV1          95  97  97  97 
TT2plus         
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Finland)
BCG
ChartChart
  99  91  90 
DTP1
ChartChart
  99  99  99  99  99  99  96  97 
DTP3
ChartChart
  98  98  98  99  99  99  90  92 
HepB3
ChartChart
 
HepB_BD
ChartChart
 
Hib3
ChartChart
  98  98  98  99  99  96 
MCV1
ChartChart
  97  97  97  97  97  96  97 
MCV2
ChartChart
 
PCV3
ChartChart
 
Pol3
ChartChart
  98  98  98  99  99  96  90  90 
RCV1
ChartChart
  97  97  97  97  97  96  97 
RotaC
ChartChart
  93  93  93  93  93 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG < 7 years; Yes children at risk
DTaPHibIPV 3, 5, 12 months; Yes
DTaPIPV 4 years; Yes
HPV Y11-Y12 (x3doses); Yes
HepB Yes Medical risk groups
Influenza_Adult Yes elderly and chronic illness, and pregnant women, health care workers
Influenza_Pediatric Yes and children with chronic illness
MMR 12 months; 6 years; Yes
Pneumo_conj 3, 5, 12 months; Yes
Rotavirus 2, 3, 5 months; Yes
Tdap 14 years; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR NA    No  No  No  No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number            

System performance

Total Nº districts in country number             NA 
Nº districts with DTP3 coverage >=80% number        
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number        
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No    No  No  No  No   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes    Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100            100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes    Yes  Yes  Yes  Yes   

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.